Literature DB >> 1140171

Intravenous infusion of prostaglandin E2 raises plasma calcium concentration in the rat.

R B Franklin, A H Tashjian.   

Abstract

Constant intravenous infusion (65 to 260 ng/min) of prostaglandin E2 (PGE2) produced an elevation of the plasma calcium concentration in unanesthetized rats in a period of 4 h. The increase in plasma calcium was related to the amount of PGE2 infused, and the hypercalcemia persisted for at least 10 h during continuous infusion. There was also a small increase in plasma inorganic phosphorus concentration. The increase in plasma calcium was not due to hemoconcentration; in fact, there was a small decrease in hematocrit during infusion of PGE2, and no change in total plasma protein concentration was detected. Infusion of PGF2, did not raise plasma calcium concentration. We conclude that under appropriate conditions, the exogenous administration of PGE2 can cause an elevation of plasma calcium in the intact rat.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1140171     DOI: 10.1210/endo-97-1-240

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

1.  Hypercalcemia and urinary excretion of cyclic AMP in bronchogenic carcinoma.

Authors:  G Francini; M Galli
Journal:  World J Surg       Date:  1977-07       Impact factor: 3.352

Review 2.  Prostaglandin-mediated hypercalcemia: a paraneoplastic syndrome.

Authors:  H W Seyberth
Journal:  Klin Wochenschr       Date:  1978-04-15

Review 3.  Incidence and pathophysiology of hypercalcemia.

Authors:  G R Mundy
Journal:  Calcif Tissue Int       Date:  1990       Impact factor: 4.333

4.  Ibuprofen inhibits localized bone resorption in the middle ear.

Authors:  M C Jungkeit; R A Chole
Journal:  Calcif Tissue Int       Date:  1991-04       Impact factor: 4.333

5.  Changes in bone and bone marrow of rabbits bearing the VX-2 carcinoma. A comparison of local and distant effects.

Authors:  A Hough; H Seyberth; J Oates; W Hartmann
Journal:  Am J Pathol       Date:  1977-06       Impact factor: 4.307

6.  Comparison of the effects of 1,25-dihydroxycholecalciferol, prostaglandin E2, and osteoclast-activating factor with parathyroid hormone on the ultrastructure of osteoclasts in cultured long bones of fetal rats.

Authors:  M E Holtrop; L G Raisz
Journal:  Calcif Tissue Int       Date:  1979       Impact factor: 4.333

7.  Primary infantile hyperparathyroidism: clinical, laboratory, and radiographic features in 21 cases.

Authors:  F Eftekhari; D K Yousefzadeh
Journal:  Skeletal Radiol       Date:  1982       Impact factor: 2.199

8.  Stimulatory effect of prostaglandin E2 on 1 alpha,25-dihydroxyvitamin D3 synthesis in rats.

Authors:  M Yamada; T Matsumoto; N Takahashi; T Suda; E Ogata
Journal:  Biochem J       Date:  1983-10-15       Impact factor: 3.857

Review 9.  Hypercalcemia and cancer: an update.

Authors:  T M Murray; R G Josse; J N Heersche
Journal:  Can Med Assoc J       Date:  1978-10-21       Impact factor: 8.262

10.  Prostaglandins E and F in endocrine diarrheagenic syndromes.

Authors:  B M Jaffe; S Condon
Journal:  Ann Surg       Date:  1976-10       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.